Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About Mitchell MCN
  • Careers
  • MCNTalk
  • Contact Us

Mitchell MCN

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About Mitchell MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / One Man’s Mission in the Realm of Rare Diseases

February 7, 2017

One Man’s Mission in the Realm of Rare Diseases

It may sound odd when first hearing it, but “rare diseases” are not unusual. In fact, an estimated 30 million people in the United States are living with one of the nearly 7,000 identified rare diseases. About 95 percent of these diseases have no approved drug treatments, and due to the small number of subjects to study and few people to sell new drugs to, rare diseases are often overlooked by doctors and scientists.

The New York Times ran an inspiring article about a man diagnosed with Castleman disease, a condition so rare that it has largely remained a mystery since the 1950s and few doctors have experience with it. Dr. David Fajgenbaum’s life changed when at 25-years -old he began experiencing odd, flu-like symptoms before his immune system went out of control and he began rapidly declining. A type of ministroke temporarily blinded his left eye, fluids leaked out of his blood vessels as his liver began failing, he gained about 70 pounds of extra fluids in two weeks, and then his brain began to slow down. At first, doctors had no idea what was going on and it wasn’t until they finally tried a huge dose of steroids that Dr. Fajgenbaum’s body began to fight back. After seven weeks of being in the hospital he was able to walk out – the beginning of a long cycle for Dr. Fajgenbaum, alternating between periods of health and horrific relapses.

However, this article is not only about Castleman disease and the incredible recovery Dr. Fajgenbaum has made. Ultimately, the doctor dove into scientific research on his disease and despite life-threatening relapses has continued to search for a cure. Progress is being made, and there is optimism about a new drug that the doctor himself has been on for over three years. David Fajgenbaum has a single-minded mission to take on his own disease in the world of medical research where discoveries come slowly and true breakthroughs can take years.

“I almost wish that every disease had a David to be a part of the charge,” – Dr. Mary Jo Lechowicz, a professor at the Emory University School of Medicine.

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

4 + 5 =

Primary Sidebar

Recent Posts

  • March Clinic Calendars Are Available
  • Mitchell MCN’s Client Portal Login Page is Changing
  • IRO Team to Host Webinar about Genetics on Dec. 5, 2019
  • December Clinic Calendars are Now Available
  • Mitchell MCN’s IRO Team to Host CEU in December

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About Mitchell MCN
  • Careers

Division Headquarters

Mitchell MCN
1301 5th Ave., Ste. 2900
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2021 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.